tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MRSN Stock Latest News

Mersana Therapeutics transferred with Buy rating at Citi
The FlyMersana Therapeutics transferred with Buy rating at Citi
1M ago
MRSN
Mersana Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Mersana Therapeutics Reports Q3 2024 Financial Results
1M ago
MRSN
Mersana Therapeutics Reports Progress in Cancer Treatments
PremiumCompany Announcements
Mersana Therapeutics Reports Progress in Cancer Treatments
1M ago
8K
MRSN
Mersana Therapeutics reports Q3 EPS (9c), consensus (17c)
PremiumThe Fly
Mersana Therapeutics reports Q3 EPS (9c), consensus (17c)
1M ago
MRSN
Mersana Therapeutics (MRSN) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Mersana Therapeutics (MRSN) Q3 Earnings Cheat Sheet
2M ago
MRSN
Mersana Therapeutics price target lowered to $5 from $6 at Citi
PremiumThe FlyMersana Therapeutics price target lowered to $5 from $6 at Citi
4M ago
MRSN
Mersana Therapeutics price target lowered to $3 from $4 at Baird
Premium
The Fly
Mersana Therapeutics price target lowered to $3 from $4 at Baird
4M ago
MRSN
Mersana Therapeutics Releases Updated Corporate Presentation
Premium
Company Announcements
Mersana Therapeutics Releases Updated Corporate Presentation
4M ago
8K
MRSN
Mersana Therapeutics sees cash runway into 2026
PremiumThe Fly
Mersana Therapeutics sees cash runway into 2026
4M ago
MRSN
Mersana Therapeutics reports Q2 EPS (20c), consensus (17c)
PremiumThe Fly
Mersana Therapeutics reports Q2 EPS (20c), consensus (17c)
4M ago
MRSN
MRSN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
MRSN Earnings this Week: How Will it Perform?
4M ago
MRSN
Mersana Therapeutics Updates Corporate Presentation Online
PremiumCompany Announcements
Mersana Therapeutics Updates Corporate Presentation Online
8M ago
8K
MRSN
Mersana sees cash, equivalents sufficient to support operating plan into 2026
PremiumThe FlyMersana sees cash, equivalents sufficient to support operating plan into 2026
8M ago
MRSN
Mersana Therapeutics reports Q1 EPS (16c), consensus (18c)
Premium
The Fly
Mersana Therapeutics reports Q1 EPS (16c), consensus (18c)
8M ago
MRSN
Mersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
Premium
The Fly
Mersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
9M ago
MRSN
Wedbush bullish on Mersana Therapeutics, upgrades to Outperform
PremiumThe Fly
Wedbush bullish on Mersana Therapeutics, upgrades to Outperform
10M ago
MRSN
Mersana Therapeutics upgraded to Buy from Hold at Truist
PremiumThe Fly
Mersana Therapeutics upgraded to Buy from Hold at Truist
10M ago
MRSN
Mersana Therapeutics upgraded to Outperform from Neutral at Wedbush
PremiumThe Fly
Mersana Therapeutics upgraded to Outperform from Neutral at Wedbush
10M ago
MRSN
Guggenheim upgrades Mersana Therapeutics on XMT-1660 potential
PremiumThe Fly
Guggenheim upgrades Mersana Therapeutics on XMT-1660 potential
10M ago
MRSN
Bad News for Mersana Therapeutics Stock: This New Risk Has Been Added
PremiumCompany AnnouncementsBad News for Mersana Therapeutics Stock: This New Risk Has Been Added
10M ago
MRSN
Mersana Therapeutics upgraded to Buy from Neutral at Guggenheim
Premium
The Fly
Mersana Therapeutics upgraded to Buy from Neutral at Guggenheim
10M ago
MRSN
Mersana Therapeutics upgraded to Buy from Neutral at BTIG
Premium
The Fly
Mersana Therapeutics upgraded to Buy from Neutral at BTIG
10M ago
MRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >